AAAAAA
Results: 1-25/40
Authors:
SPEICH R
IMHOF E
VOGT M
GROSSENBACHER M
ZIMMERLI W
Citation: R. Speich et al., EFFICACY, SAFETY, AND TOLERANCE OF PIPERACILLIN TAZOBACTAM COMPARED TO CO-AMOXICLAV PLUS AN AMINOGLYCOSIDE IN THE TREATMENT OF SEVERE PNEUMONIA/, European journal of clinical microbiology & infectious diseases, 17(5), 1998, pp. 313-317
Authors:
FLUCKIGER U
FREI R
ZIMMERLI W
WIDMER AF
Citation: U. Fluckiger et al., COMPARISON OF DISTRIBUTION OF MICROBIOLOGICAL ISOLATES IN INTENSIVE-CARE UNITS (ICUS) AND WARDS - A MARKER FOR EFFECTIVE INFECTION-CONTROL IN ICUS, Infection control and hospital epidemiology, 19(9), 1998, pp. 70-70
Authors:
ZIMMERLI W
WIDMER AF
BLATTER M
FREI R
OCHSNER PE
Citation: W. Zimmerli et al., ROLE OF RIFAMPIN FOR TREATMENT OF ORTHOPEDIC IMPLANT-RELATED STAPHYLOCOCCAL INFECTIONS - A RANDOMIZED CONTROLLED TRIAL, JAMA, the journal of the American Medical Association, 279(19), 1998, pp. 1537-1541
Authors:
SCHWANK S
RAJACIC Z
ZIMMERLI W
BLASER J
Citation: S. Schwank et al., IMPACT OF BACTERIAL BIOFILM FORMATION ON IN-VITRO AND IN-VIVO ACTIVITIES OF ANTIBIOTICS, Antimicrobial agents and chemotherapy, 42(4), 1998, pp. 895-898
Authors:
MINDERMANN T
ZIMMERLI W
GRATZL O
Citation: T. Mindermann et al., RIFAMPIN CONCENTRATIONS IN VARIOUS COMPARTMENTS OF THE HUMAN BRAIN - A NOVEL METHOD FOR DETERMINING DRUG LEVELS IN THE CEREBRAL EXTRACELLULAR-SPACE, Antimicrobial agents and chemotherapy, 42(10), 1998, pp. 2626-2629
Authors:
LANDMANN R
LINK S
SANSANO S
RAJACIC Z
ZIMMERLI W
Citation: R. Landmann et al., SOLUBLE CD14 ACTIVATES MONOCYTIC CELLS INDEPENDENTLY OF LIPOPOLYSACCHARIDE, Infection and immunity, 66(5), 1998, pp. 2264-2271
Authors:
BASSETTI S
FREI R
ZIMMERLI W
Citation: S. Bassetti et al., FUNGEMIA WITH SACCHAROMYCES-CEREVISIAE AFTER TREATMENT WITH SACCHAROMYCES-BOULARDII, The American journal of medicine, 105(1), 1998, pp. 71-72
Authors:
TIETZ A
SPONAGEL L
ERB P
BUCHER H
BATTEGAY M
ZIMMERLI W
Citation: A. Tietz et al., EOSINOPHILIA IN PATIENTS INFECTED WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS, European journal of clinical microbiology & infectious diseases, 16(9), 1997, pp. 675-677
Authors:
BAUER TM
PIPPERT H
ZIMMERLI W
Citation: Tm. Bauer et al., VERTEBRAL OSTEOMYELITIS CAUSED BY GROUP-B STREPTOCOCCI (STREPTOCOCCUS-AGALACTIAE) SECONDARY TO URINARY-TRACT INFECTION, European journal of clinical microbiology & infectious diseases, 16(3), 1997, pp. 244-246
Authors:
ZIMMERLI W
Citation: W. Zimmerli, EXPERIMENTAL FOREIGN-BODY ASSOCIATED INFE CTIONS, Medecine et maladies infectieuses, 27, 1997, pp. 181-187
Authors:
ZIMMERLI W
Citation: W. Zimmerli, EXPERIMENTAL FOREIGN-BODY ASSOCIATED INFECTIONS, Medecine et maladies infectieuses, 27, 1997, pp. 188-194
Authors:
TRAMPUZ A
ZIMMERLI W
Citation: A. Trampuz et W. Zimmerli, HIV-ASSOCIATED PULMONARY-DISEASES, Schweizerische medizinische Wochenschrift, 127(42), 1997, pp. 1725-1733
Authors:
ZIMMERLI W
WIDMER AF
Citation: W. Zimmerli et Af. Widmer, IBUPROFEN IN PATIENTS WITH SEPSIS, The New England journal of medicine, 337(10), 1997, pp. 710-710
Authors:
ZIMMERLI W
Citation: W. Zimmerli, ANTIBIOTIC-PROPHYLAXIS IN THE ENT FIELD, HNO. Hals-, Nasen-, Ohrenarzte, 45(6), 1997, pp. 421-423
Authors:
BREGENZER T
FREI R
WIDMER AF
SEILER W
PROBST W
MATTARELLI G
ZIMMERLI W
Citation: T. Bregenzer et al., LOW-RISK OF BACTEREMIA DURING CATHETER REPLACEMENT IN PATIENTS WITH LONG-TERM URINARY CATHETERS, Archives of internal medicine, 157(5), 1997, pp. 521-525
Authors:
NUESCH R
BATTEGAY M
ZIMMERLI W
THUMSHIRN M
GILLI L
ITIN PH
Citation: R. Nuesch et al., ORAL MANIFESTATION OF DISSEMINATED MYCOBACTERIUM-KANSASII INFECTION IN A PATIENT WITH AIDS, Dermatology, 192(2), 1996, pp. 183-184
Authors:
SCHEIDEGGER C
ZIMMERLI W
Citation: C. Scheidegger et W. Zimmerli, INCIDENCE AND SPECTRUM OF SEVERE MEDICAL COMPLICATIONS AMONG HOSPITALIZED HIV-SERONEGATIVE AND HIV-SEROPOSITIVE NARCOTIC DRUG-USERS, AIDS, 10(12), 1996, pp. 1407-1414
Authors:
ZIMMERLI W
SANSANO S
WITTKE B
Citation: W. Zimmerli et al., PHARMACOKINETICS OF CEFETAMET IN PLASMA AND SKIN BLISTER FLUID, Antimicrobial agents and chemotherapy, 40(1), 1996, pp. 102-104
Authors:
BREGENZER T
EVISONECKSTEIN AC
FREI R
ZIMMERLI W
Citation: T. Bregenzer et al., CLINICAL FINDINGS AND PROGNOSIS OF CANDID EMIAS, Schweizerische medizinische Wochenschrift, 126(43), 1996, pp. 1829-1833
Authors:
ZIMMERLI W
LEW DP
Citation: W. Zimmerli et Dp. Lew, USE OF AMINOGLYCOSIDES - THE SWISS CONSENSUS, Schweizerische medizinische Wochenschrift, 126(17), 1996, pp. 5-8
Authors:
STOECKLI TC
ZIMMERLI W
MAECKE HR
FRIDRICH R
Citation: Tc. Stoeckli et al., COMPARISON OF CHEMOTAXIS AND SUPEROXIDE GENERATION OF INDIUM-111-OXINE-LABELED AND TECHNETIUM-99M-HMPAO-LABELED GRANULOCYTES, Scandinavian journal of clinical & laboratory investigation, 56(4), 1996, pp. 305-309
Authors:
HOFFMANN R
ZIMMERLI W
VRANJES N
LARGIADER F
Citation: R. Hoffmann et al., ADVANTAGES OF THE LASER IN LAPAROSCOPIC C HOLECYSTECTOMY, Langenbecks Archiv fur Chirurgie, 1996, pp. 589-592
Authors:
LANDMANN R
REBER AM
SANSANO S
ZIMMERLI W
Citation: R. Landmann et al., FUNCTION OF SOLUBLE CD14 IN SERUM FROM PATIENTS WITH SEPTIC SHOCK, The Journal of infectious diseases, 173(3), 1996, pp. 661-668
Authors:
LANDMANN R
KNOPF HP
LINK S
SANSANO S
SCHUMANN R
ZIMMERLI W
Citation: R. Landmann et al., HUMAN MONOCYTE CD14 IS UP-REGULATED BY LIPOPOLYSACCHARIDE, Infection and immunity, 64(5), 1996, pp. 1762-1769
Authors:
LEW DP
GARBINO J
GERBER AU
SUDRE P
AUCKENTHALER R
FRANCIOLI P
RUEF C
ZIMMERLI W
ZWAHLEN A
REGAMEY C
VOGT M
Citation: Dp. Lew et al., USE OF ANTIMICROBIALS IN SWISS HOSPITALS, Drugs, 52, 1996, pp. 88-91